49 results on '"de Boer, Jan"'
Search Results
2. Contributors
- Author
-
Aldana, Ana A., primary, Alexander, Morgan R., additional, Atala, Anthony, additional, Badylak, Stephen F., additional, Baker, Matthew B., additional, Bauer, Jurica, additional, Black, Cameron, additional, Bobbala, Sharan, additional, Brittberg, Mats, additional, Brook, Gary A., additional, Buchanan, Fraser, additional, Carlier, Aurélie, additional, Chen, Saray, additional, Claes, Evan, additional, Cohen, Smadar, additional, Connelly, John, additional, Dalby, Matthew J., additional, Dalton, Paul D., additional, Dawson, Jonathan I., additional, de Boer, Jan, additional, Desmet, Tim, additional, Donnelly, Hannah, additional, Donvil, Filip, additional, Dziki, Jenna L., additional, Egger, Dominik, additional, Filippi, Miriam, additional, Gensler, Marius, additional, Gibbs, David, additional, Gibbs, Susan, additional, Hannen, Rosalind, additional, Hansmann, Jan, additional, Harvey, Alan R., additional, Heck, Tommy, additional, Herrmann, Marietta, additional, Hook, Andrew L., additional, Hubbell, Jeffrey A., additional, Hutmacher, Dietmar W., additional, Hynes, Clara Grace, additional, Joly, Johan, additional, Jorgensen, Adam M., additional, Kanczler, Janos, additional, Karperien, Marcel, additional, Kasper, Cornelia, additional, Kerr, Candace L., additional, Kilian, Kristopher A., additional, Kreß, Sebastian, additional, LaPointe, Vanessa, additional, Laschke, Matthias W., additional, Lindahl, Anders, additional, Londono, Ricardo, additional, Luyten, Frank P., additional, Marechal, Marina, additional, Martino, Mikaël M., additional, Moos, Malcolm, additional, Moroni, Lorenzo, additional, Morra, Emily, additional, Myers, Simon, additional, Nebel, Sabrina, additional, Nie, Minghao, additional, Nisbet, David R., additional, O'Neill, Kelly L., additional, Ojeh, Nkemcho, additional, Oreffo, Richard OC., additional, Oudega, Martin, additional, Passier, Robert, additional, Pêgo, Ana Paula, additional, Pittenger, Mark F., additional, Plant, Giles W., additional, Rice, Jeffrey J., additional, Roelen, Bernard A.J., additional, Schaschkow, Anaïs, additional, Scherberich, Arnaud, additional, Schrooten, Jan, additional, Scott, Evan A., additional, Sicari, Brian M., additional, Sonnaert, Maarten, additional, Später, Thomas, additional, Takeuchi, Shoji, additional, Tandon, Biranche, additional, Tare, Rahul, additional, Truckenmüller, Roman, additional, Tsimbouri, Monica, additional, Uquillas, Jorge Alfredo, additional, Van Assche, Dieter, additional, Vermeulen, Steven, additional, Verrier, Sophie, additional, Walsh, Pamela, additional, and Winkler, David A., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Contributors
- Author
-
Asnaghi, M. Adelaide, primary, Aerts, Jean-Marie, additional, Alakpa, Enateri V., additional, Alexander, Morgan R., additional, Alini, Mauro, additional, Alm, Jessica J., additional, Atala, Anthony, additional, Badylak, Stephen F., additional, Groot, Florence Barrère-de, additional, Black, Cameron, additional, Brittberg, Mats, additional, Cha, Chaenyung, additional, Cohen, Smadar, additional, Dalby, Matthew J., additional, Dalton, Paul D., additional, Davison, Noel L., additional, Dawson, Jonathan I., additional, de Boer, Jan, additional, DeRuiter, Marco C., additional, Engler, Adam J., additional, Geris, Liesbet, additional, Gibbs, Susan, additional, Gibbs, David, additional, Gittenberger-de Groot, Adriana C., additional, Grijpma, Dirk W., additional, Han, Chungmin, additional, Harvey, Alan R., additional, Herrmann, Marietta, additional, Hierck, Beerend P., additional, Hook, Andrew L., additional, Hubbell, Jeffrey A., additional, Hutmacher, Dietmar W., additional, Joly, Johan, additional, Kanczler, Janos, additional, Karperien, Marcel, additional, Kerr, Candace, additional, Khademhosseini, Ali, additional, Labuz, Joseph M., additional, Lambrechts, Toon, additional, LaPointe, Vanessa L.S., additional, Laschke, Matthias W., additional, Le Blanc, Katarina, additional, Levenberg, Shulamit, additional, Lindahl, Anders, additional, Londono, Ricardo, additional, Luyten, Frank P., additional, Mantalaris, Athanasios, additional, Martin, Ivan, additional, Martino, Mikaël M., additional, McNamara, Laura E., additional, Meijer, Dies, additional, Moroni, Lorenzo, additional, Myers, Simon, additional, Navsaria, Harshad, additional, Ojeh, Nkemcho, additional, Oreffo, Richard O.C., additional, Oudega, Martin, additional, Papantoniou, Ioannis, additional, Park, Jaesung, additional, Piraino, Francesco, additional, Pittenger, Mark F., additional, Plant, Giles W., additional, Poelmann, Rob E., additional, Qian, Hong, additional, Reischl, Ilona, additional, Rice, Jeffrey J., additional, Roelen, Bernard A.J., additional, Rouwkema, Jeroen, additional, Ruvinov, Emil, additional, Sandberg, Jason M., additional, Scherberich, Arnaud, additional, Schrooten, Jan, additional, Scott, Evan A., additional, Shandalov, Yulia, additional, Sicari, Brian M., additional, Smith, Timothy, additional, Sohier, Jérôme, additional, Sonnaert, Maarten, additional, Takayama, Shuichi, additional, Tare, Rahul, additional, Truckenmüller, Roman, additional, Tsimbouri, Penelope M., additional, Turner, Lesley-Anne, additional, Van Assche, Dieter, additional, van Blitterswijk, Clemens A., additional, Vanlauwe, Johan, additional, Verrier, Sophie, additional, Welin, Stellan, additional, Wendt, David, additional, Winkler, Dave A., additional, and Woodfield, Tim B.F., additional
- Published
- 2015
- Full Text
- View/download PDF
4. Cellular Signaling
- Author
-
LaPointe, Vanessa L.S., primary, de Boer, Jan, additional, and Engler, Adam J., additional
- Published
- 2014
- Full Text
- View/download PDF
5. Preface
- Author
-
Hendriks, Margriet M.W.B., primary, de Boer, Jan H., additional, and Smidle, Age K., additional
- Published
- 1996
- Full Text
- View/download PDF
6. Chapter 4 Robustness criteria; Incorporating robustness explicitly in optimization procedures utilizing multicriteria methods
- Author
-
de Boer, Jan H., primary
- Published
- 1996
- Full Text
- View/download PDF
7. Tissue Formation during Embryogenesis
- Author
-
Karperien, Marcel, Roelen, Bernard A.J., Poelmann, Rob E., Gittenberger-de Groot, Adriana, Hierck, Beerend P., DeRuiter, Marco C., Meijer, Dies, Gibbs, Susan, van Blitterswijk, Clemens A., de Boer, Jan, Dermatology, CCA - Immuno-pathogenesis, MOVE Research Institute, Faculty of Science and Technology, and Developmental BioEngineering
- Subjects
Cell type ,Mesoderm ,Embryonic stem cells ,and Neural Crest) ,Cellular differentiation ,Organogenesis ,Ectoderm ,Germ layer ,Biology ,Cell–cell contacts ,Germ layer (Mesoderm, Endoderm, Ectoderm, and Neural Crest) ,medicine ,METIS-310673 ,Germ layer (Mesoderm ,Epithelial-to-mesenchyme transition ,Endoderm ,Neural crest ,Morphogenic gradients and paracrine signaling ,Developmental (re)engineering ,Environmental adaptation ,Cell biology ,medicine.anatomical_structure ,IR-100046 ,Immunology - Abstract
The formation of functional organs and tissues during embryonic development is a complex process involving multiple cell types derived from ectoderm, mesoderm, endoderm, and the neural crest. These cell types interact via diverse mechanisms. Examples of such mechanisms are direct cell–cell contacts and paracrine signaling by morphogenic gradients. Cell behavior during organogenesis is dynamic and is dependent on cell movements of a subset of cells. Other cells revert their phenotype by a process called epithelial-to-mesenchyme transition and may become migratory. To obtain functional organs, cells respond to environmental signals like pulsatile blood flow by activation of adaptive signaling mechanisms, which direct tissue architecture. The timely, proper dosing and sequential integration of all these elements during organogenesis specifies cell types and shapes the organ's form and function in the embryo. Tissue engineering relies on reiteration of these developmental processes and aims to combine this knowledge with typical engineering disciplines to generate functional substitutes to replace lost or worn out tissue. This process is known as developmental (re)engineering.
- Published
- 2015
8. Tissue Engineering, 2nd edition
- Author
-
de Boer, Jan
- Subjects
METIS-308263 ,IR-95060 - Published
- 2014
9. Stem cells
- Author
-
Jukes, Jojanneke, Both, Sanne, Post, Janine, van Blitterswijk, Clemens, Karperien, Marcel, de Boer, Jan, and van Blitterswijk, Clemens A.
- Subjects
METIS-253650 ,KOSR ,Amniotic epithelial cells ,Clinical uses of mesenchymal stem cells ,Embryoid body ,Biology ,Stem cell ,Embryonic stem cell ,Adult stem cell ,Stem cell transplantation for articular cartilage repair ,Cell biology - Abstract
Publisher Summary This chapter defines stem cells and their properties. It identifies the major differences between embryonic and adult stem cells. Stem cells can be defined by two properties: the ability to make identical copies of themselves and the ability to form other cell types of the body. These properties are also referred to as “stemness.” Stem cells may potentially provide an unlimited supply of cells that can form any of the hundreds of specialized cells in the body. It is because of these properties that stem cells are an interesting cell source for tissue engineers. Stem cells can be divided into two main groups: embryonic and adult or somatic stem cells. Embryonic stem cells are responsible for embryonic and fetal development and growth. In the human body, adult stem cells are responsible for growth, tissue maintenance and regeneration and repair of diseased or damaged tissue. Embryonic stem cells do not exist in the body. When cells are isolated from the inner cell mass of the blastocyst, they can be massively expanded in the laboratory, while maintaining their pluripotency. Adult stem cells are undifferentiated cells, which reside in differentiated tissues.
- Published
- 2008
10. Changes in bile acid composition are correlated with reduced intestinal cholesterol uptake in intestine-specific WASH-deficient mice.
- Author
-
Heida A, van Dijk T, Smit M, Koehorst M, Koster M, Kloosterhuis N, Havinga R, Bloks VW, Wolters JC, de Bruin A, Kuivenhoven JA, de Boer JF, Kuipers F, and van de Sluis B
- Subjects
- Animals, Female, Humans, Male, Mice, Biological Transport, Cholesterol metabolism, Liver metabolism, Bile Acids and Salts metabolism, Intestines
- Abstract
The Wiskott-Aldrich syndrome protein and SCAR homolog (WASH) complex is a pentameric protein complex localized at endosomes, where it facilitates the transport of numerous receptors from endosomes toward the plasma membrane. Recent studies have shown that the WASH complex plays an essential role in cholesterol and glucose homeostasis in humans and mice. To investigate the physiological importance of intestinal WASH, we ablated the WASH component WASHC1 specifically in murine enterocytes. Male and female intestine-specific WASHC1-deficient mice (Washc1
IKO ) were challenged with either a standard chow diet or a high-cholesterol (1.25 %) diet (HCD). Washc1IKO mice fed a standard diet did not present any apparent phenotype, but when fed an HCD, their hepatic cholesterol levels were ~ 50 % lower compared to those observed in control mice. The intestinal cholesterol absorption was almost 2-fold decreased in Washc1IKO mice, which translated into increased fecal neutral sterol loss. The intestinal expression of cholesterogenic genes, such as Hmgcs1, Hmgcr, and Ldlr, was significantly higher in Washc1IKO mice than in control mice and correlated with increased whole-body de novo cholesterol synthesis, likely to compensate for impaired intestinal cholesterol absorption. Unexpectedly, the ratio of biliary 12α-/non-12α-hydroxylated bile acids (BAs) was decreased in Washc1IKO mice and reversing this reduced ratio by feeding the mice with the HCD supplemented with 0.5 % (w/w) sodium cholate normalized the improvement of hepatic cholesterol levels in Washc1IKO mice. Our data indicate that the intestinal WASH complex plays an important role in intestinal cholesterol absorption, likely by modulating biliary BA composition., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
11. The loop of phenotype: Dynamic reciprocity links tenocyte morphology to tendon tissue homeostasis.
- Author
-
Dede Eren A, Vermeulen S, Schmitz TC, Foolen J, and de Boer J
- Subjects
- Tendons physiology, Extracellular Matrix metabolism, Homeostasis, Phenotype, Mechanotransduction, Cellular physiology, Tenocytes
- Abstract
Cells and their surrounding extracellular matrix (ECM) are engaged in dynamic reciprocity to maintain tissue homeostasis: cells deposit ECM, which in turn presents the signals that define cell identity. This loop of phenotype is obvious for biochemical signals, such as collagens, which are produced by and presented to cells, but the role of biomechanical signals is also increasingly recognised. In addition, cell shape goes hand in hand with cell function and tissue homeostasis. Aberrant cell shape and ECM is seen in pathological conditions, and control of cell shape in micro-fabricated platforms disclose the causal relationship between cell shape and cell function, often mediated by mechanotransduction. In this manuscript, we discuss the loop of phenotype for tendon tissue homeostasis. We describe cell shape and ECM organization in normal and diseased tissue, how ECM composition influences tenocyte shape, and how that leads to the activation of signal transduction pathways and ECM deposition. We further describe the use of technologies to control cell shape to elucidate the link between cell shape and its phenotypical markers and focus on the causal role of cell shape in the loop of phenotype. STATEMENT OF SIGNIFICANCE: The dynamic reciprocity between cells and their surrounding extracellular matrix (ECM) influences biomechanical and biochemical properties of ECM as well as cell function through activation of signal transduction pathways that regulate gene and protein expression. We refer to this reciprocity as Loop of Phenotype and it has been studied and demonstrated extensively by using micro-fabricated platforms to manipulate cell shape and cell fate. In this manuscript, we discuss this concept in tendon tissue homeostasis by giving examples in healthy and pathological tenson tissue. Furthermore, we elaborate this by showing how biomaterials are used to feed this reciprocity to manipulate cell shape and function. Finally, we elucidate the link between cell shape and its phenotypical markers and focus on the activation of signal transduction pathways and ECM deposition., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
12. Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice.
- Author
-
van Eenige R, Ying Z, Tramper N, Wiebing V, Siraj Z, de Boer JF, Lambooij JM, Guigas B, Qu H, Coskun T, Boon MR, Rensen PCN, and Kooijman S
- Subjects
- Animals, Female, Humans, Mice, Apolipoprotein E3, Cholesterol Ester Transfer Proteins, Diabetes Mellitus, Type 2, Inflammation, Atherosclerosis drug therapy, Glucagon-Like Peptide-1 Receptor agonists, Receptors, Gastrointestinal Hormone agonists
- Abstract
Background and Aims: Combined agonism of the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP1R) is superior to single GLP1R agonism in terms of glycemic control and lowering body weight in individuals with obesity and with or without type 2 diabetes mellitus. As both GIPR and GLP1R signaling have also been implicated in improving inflammatory responses and lipid handling, two crucial players in atherosclerosis development, here we aimed to investigate the effects of combined GIPR/GLP1R agonism in APOE*3-Leiden.CETP mice, a well-established mouse model for human-like lipoprotein metabolism and atherosclerosis development., Methods: Female APOE*3-Leiden.CETP mice were fed a Western-type diet (containing 16% fat and 0.15% cholesterol) to induce dyslipidemia, and received subcutaneous injections with either vehicle, a GIPR agonist (GIPFA-085), a GLP1R agonist (GLP-140) or both agonists. In the aortic root area, atherosclerosis development was assessed., Results: Combined GIPR/GLP1R agonism attenuated the development of severe atherosclerotic lesions, while single treatments only showed non-significant improvements. Mechanistically, combined GIPR/GLP1R agonism decreased markers of systemic low-grade inflammation. In addition, combined GIPR/GLP1R agonism markedly lowered plasma triglyceride (TG) levels as explained by reduced hepatic very-low-density lipoprotein (VLDL)-TG production as well as increased TG-derived fatty acid uptake by brown and white adipose tissue which was coupled to enhanced hepatic uptake of core VLDL remnants., Conclusions: Combined GIPR/GLP1R agonism attenuates atherosclerosis severity by diminishing inflammation and increasing VLDL turnover. We anticipate that combined GIPR/GLP1R agonism is a promising strategy to lower cardiometabolic risk in humans., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This work was also supported by a Lilly Research Award Program [LRAP] Award (to P.C.N.R. and S.K.). HQ and TC are employees and shareholders of Eli Lilly and Company. Eli Lilly and Company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
13. An off-the-shelf decellularized and sterilized human bone-ACL-bone allograft for anterior cruciate ligament reconstruction.
- Author
-
Uquillas JA, Spierings J, van der Lande A, Eren AD, Bertrand M, Yuan H, Yuan H, van Groningen B, Janssen R, Ito K, de Boer J, and Foolen J
- Subjects
- Allografts surgery, Animals, Carbon Dioxide, Collagen, Humans, Rupture, Sterilization methods, Swine, Anterior Cruciate Ligament surgery, Anterior Cruciate Ligament Reconstruction methods
- Abstract
Approximately 1% of active individuals participating in sports rupture their anterior cruciate ligaments (ACL) every year, which is currently reconstructed using tendon autografts. Upon reconstruction, clinical issues of concern are ACL graft rupture, persistent knee instability, limited return to sports, and early onset of osteoarthritis (OA). This happens because tendon autografts do not have the same compositional, structural, and mechanical properties as a native ACL. To overcome these problems, we propose to use decellularized bone-ACL-bone allografts in ACL reconstruction (ACLR) as a mechanically robust, biocompatible, and immunologically safe alternative to autografts. Here, a decellularization protocol combined with sterilization using supercritical carbon dioxide (scCO
2 ) was used to thoroughly decellularize porcine and human ACLs attached to tibial and femoral bone blocks. The specimens were named ultrACLean and their compositional, structural, and mechanical properties were determined. Our results indicate that: 1) decellularization of ultrACLean allografts leads to the removal of nearly 97% of donor cells, 2) ultrACLean has mechanical properties which are not different to native ACL, 3) ultrACLean maintained similar collagen content and decreased GAG content compared to native ACL, and 4) ultrACLean is not cytotoxic to seeded tendon-derived cells in vitro. Results from an in vivo pilot experiment showed that ultrACLean is biocompatible and elicits a moderate immunological response. In summary, ultrACLean has proven to be a mechanically competent and biocompatible graft with the potential to be used in ACLR surgery., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
14. Short-term obeticholic acid treatment does not impact cholangiopathy in Cyp2c70-deficient mice with a human-like bile acid composition.
- Author
-
Li R, Hovingh MV, Koehorst M, de Blaauw P, Verkade HJ, de Boer JF, and Kuipers F
- Subjects
- Animals, Female, Fibrosis, Humans, Male, Mice, Ursodeoxycholic Acid, Bile Acids and Salts, Chenodeoxycholic Acid analogs & derivatives, Chenodeoxycholic Acid pharmacology
- Abstract
Cyp2c70
-/- mice with a human-like bile acid (BA) composition, lacking hydrophilic muricholic acids (MCAs), have been reported to display cholangiopathy and biliary fibrosis with female preponderance that can be reversed by ursodeoxycholic acid (UDCA). Obeticholic acid (OCA), a steroidal BA-like FXR agonist, has been shown to improve liver function in patients with primary biliary cholangitis and is approved as second-line treatment for patients with an inadequate response or intolerance to UDCA. Here, we investigated the impact of OCA on BA hydrophobicity and cholangiopathy in Cyp2c70-/- mice. Male and female wild-type (WT) and Cyp2c70-/- mice were fed a chow diet with or without 10 mg/kg/day OCA for 4 weeks. OCA accounted for 1-5% of biliary BAs, with larger enrichments in Cyp2c70-/- than in WT mice. In WT mice, OCA induced a more hydrophilic, MCA-rich BA pool. In Cyp2c70-/- mice, however, BA pool became more hydrophobic with a larger proportion of chenodeoxycholic acid, attributable to a reduction of BA 12α-hydroxylation. OCA treatment reduced fecal BA excretion, indicating repression of hepatic BA synthesis in both WT and Cyp2c70-/- mice. OCA did, however, not impact on markers of liver (dys)function in plasma nor did it ameliorate cholangiopathy and fibrosis in male or female Cyp2c70-/- mice. OCA treatment also did not affect the expression of genes involved in fibrosis, inflammation and cellular senescence. In conclusion, 4 weeks of OCA treatment oppositely modulates the hydrophobicity of the BA pool in WT and Cyp2c70-/- mice, but does not improve or worsen the characteristic sex-dependent liver pathology in Cyp2c70-/- mice., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
15. Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer.
- Author
-
Willemsen ACH, Kok A, Baijens LWJ, de Boer JP, de Bree R, Devriese LA, Driessen CML, van Herpen CML, Hoebers FJP, Kaanders JHAM, Karsten RT, van Kuijk SMJ, Lalisang RI, Navran A, Pereboom SR, Schols AMWJ, Terhaard CHJ, and Hoeben A
- Subjects
- Biomarkers analysis, Chemoradiotherapy adverse effects, Chemoradiotherapy statistics & numerical data, Feeding and Eating Disorders etiology, Feeding and Eating Disorders therapy, Female, Humans, Male, Middle Aged, Netherlands, Predictive Value of Tests, Radiation Dosage, Retrospective Studies, Clinical Decision Rules, Enteral Nutrition standards, Gastrostomy standards, Head and Neck Neoplasms therapy, Squamous Cell Carcinoma of Head and Neck therapy
- Abstract
Background & Aims: Patients who receive chemoradiotherapy or bioradiotherapy (CRT/BRT) for locally advanced head and neck squamous cell carcinoma (LAHNSCC) often experience high toxicity rates interfering with oral intake, causing tube feeding (TF) dependency. International guidelines recommend gastrostomy insertion when the expected use of TF exceeds 4 weeks. We aimed to develop and externally validate a prediction model to identify patients who need TF ≥ 4 weeks and would benefit from prophylactic gastrostomy insertion., Methods: A retrospective multicenter cohort study was performed in four tertiary head and neck cancer centers in the Netherlands. The prediction model was developed using data from University Medical Center Utrecht and the Netherlands Cancer Institute and externally validated using data from Maastricht University Medical Center and Radboud University Medical Center. The primary endpoint was TF dependency ≥4 weeks initiated during CRT/BRT or within 30 days after CRT/BRT completion. Potential predictors were extracted from electronic health records and radiotherapy dose-volume parameters were calculated., Results: The developmental and validation cohort included 409 and 334 patients respectively. Multivariable analysis showed predictive value for pretreatment weight change, texture modified diet at baseline, ECOG performance status, tumor site, N classification, mean radiation dose to the contralateral parotid gland and oral cavity. The area under the receiver operating characteristics curve for this model was 0.73 and after external validation 0.62. Positive and negative predictive value for a risk of 90% or higher for TF dependency ≥4 weeks were 81.8% and 42.3% respectively., Conclusions: We developed and externally validated a prediction model to estimate TF-dependency ≥4 weeks in LAHNSCC patients treated with CRT/BRT. This model can be used to guide personalized decision-making on prophylactic gastrostomy insertion in clinical practice., Competing Interests: Conflict of interest Anna C.H. Willemsen, Annemieke Kok, Jan Paul de Boer, Remco de Bree, Chantal M.L. Driessen, Johannes H.A.M. Kaanders, Rebecca T. Karsten, Sander M.J. van Kuijk, Roy I. Lalisang, Arash Navran, Susanne R. Pereboom, Annemie M.W.J. Schols, Chris H.J. Terhaard, and Ann Hoeben declare that they have no conflict of interest. Laura W.J. Baijens. Consulting or advisory role: Phagenesis Limited, member of the Independent FEES Review Committee for the PhINEST study. Lot A. Devriese. Consulting or advisory role: MSD, Bristol Myers Squibb. Frank J.P. Hoebers. Consulting or advisory role: Bristol Myers Squibb. Carla M.L. van Herpen. Consulting or advisory role: Bayer, Bristol Myers Squibb, MSD, Regeneron, TRK Fusion Cancer Medical. Research Funding: Astra Zeneca, Bristol Myers Squibb, MSD, Merck, Ipsen, Novartis, Sanofi, France., (Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
16. Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer.
- Author
-
Bourhis J, Stein A, Paul de Boer J, Van Den Eynde M, Gold KA, Stintzing S, Becker JC, Moran M, Schroeder A, Pennock G, Salmio S, Esser R, and Ciardiello F
- Subjects
- Antibodies, Monoclonal, Humanized administration & dosage, Cetuximab administration & dosage, Clinical Trials as Topic, Humans, Neoplasms pathology, Prognosis, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Neoplasms drug therapy
- Abstract
Treatment outcomes have improved with the advent of immune checkpoint inhibitors and small molecule inhibitors. However, many patients do not respond with single agents. Consequently, ongoing research is focused on the use of combination therapies to increase clinical efficacy by potential synergistic effects. Here, we outline ongoing trials and review the rationale and evidence for the combination of avelumab, an anti-programmed death ligand 1 (PD-L1) immunoglobulin G1 (IgG1) monoclonal antibody (mAb), with cetuximab, an anti-epidermal growth factor receptor (EGFR) IgG1 mAb. Avelumab is approved as a monotherapy for the treatment of Merkel cell carcinoma and urothelial carcinoma, and in combination with axitinib for renal cell carcinoma; cetuximab is approved in combination with chemotherapy for the treatment of squamous cell carcinoma of the head and neck (SCCHN) and RAS wild-type metastatic colorectal cancer, and in combination with radiation therapy for SCCHN. Avelumab binds to PD-L1 expressed on tumor cells and immune regulatory cells, thus blocking its interaction with programmed death 1 and reventing T-cell suppression; cetuximab inhibits the EGFR signaling pathway, inhibiting proliferation and inducing apoptosis. Both therapies have complementary mechanisms of action and may also activate the immune system to induce innate effector function through the binding of their Fc regions to natural killer (NK) cells. Furthermore, cetuximab combined with chemotherapy has been shown to induce immunogenic cell death and leads to an increase in tumor-infiltrating CD8+ T and NK cells, which should synergize with the immunostimulatory effects of avelumab. Prospective studies will investigate this combination and inform future treatment strategies., (Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
17. Invited response to "MELD calibration".
- Author
-
Goudsmit BFJ, Putter H, Tushuizen ME, de Boer J, Vogelaar S, Alwayn IPJ, van Hoek B, and Braat AE
- Subjects
- Calibration, Humans, Severity of Illness Index, Waiting Lists, End Stage Liver Disease, Sodium
- Published
- 2021
- Full Text
- View/download PDF
18. Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant region.
- Author
-
Goudsmit BFJ, Putter H, Tushuizen ME, de Boer J, Vogelaar S, Alwayn IPJ, van Hoek B, and Braat AE
- Subjects
- Adult, Humans, Severity of Illness Index, Sodium, Waiting Lists, End Stage Liver Disease surgery, Liver Transplantation
- Abstract
The MELD score is used in the Eurotransplant (ET) region to allocate liver grafts. Hyponatremia in cirrhotic patients is an important predictor of death but is not incorporated in MELD. This study investigated the performance of the MELD-Na score for the ET region. All adult patients with chronic liver disease on the ET liver transplantation waiting list (WL) allocated through lab MELD scores were included. The MELD-corrected effect of serum sodium (Na) concentration at listing on the 90-day WL mortality was calculated using Cox regression. The MELD-Na performance was assessed with c-indices, calibration per decile and Brier scores. The reclassification from MELD to MELD-Na score was calculated to estimate the impact of MELD-Na-based allocation in the ET region. For the 5223 included patients, the risk of 90-day WL death was 2.9 times higher for hyponatremic patients. The MELD-Na had a significantly higher c-index of 0.847 (SE 0.007) and more accurate 90-day mortality prediction compared to MELD (Brier score of 0.059 vs 0.061). It was estimated that using MELD-Na would reduce WL mortality by 4.9%. The MELD-Na score yielded improved prediction of 90-day WL mortality in the ET region and using MELD-Na for liver allocation will very likely reduce WL mortality., (© 2020 The Authors. American Journal of Transplantation published by Wiley Periodicals LLC on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons.)
- Published
- 2021
- Full Text
- View/download PDF
19. Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70 -/- mice by reducing fat absorption.
- Author
-
Li R, Palmiotti A, de Vries HD, Hovingh MV, Koehorst M, Mulder NL, Zhang Y, Kats K, Bloks VW, Fu J, Verkade HJ, de Boer JF, and Kuipers F
- Subjects
- Animals, Cytochrome P-450 Enzyme System deficiency, Diet, Western adverse effects, Fatty Liver chemically induced, Fatty Liver metabolism, Female, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Non-alcoholic Fatty Liver Disease chemically induced, Non-alcoholic Fatty Liver Disease metabolism, Non-alcoholic Fatty Liver Disease prevention & control, Bile Acids and Salts biosynthesis, Cytochrome P-450 Enzyme System metabolism, Fatty Liver prevention & control
- Abstract
Bile acids (BAs) play important roles in lipid homeostasis, and BA signaling pathways serve as therapeutic targets for nonalcoholic fatty liver disease (NAFLD). Recently, we generated cytochrome P450, family 2, subfamily C, polypeptide 70 (Cyp2c70
-/- ) mice with a human-like BA composition lacking mouse-/rat-specific muricholic acids to accelerate translation from mice to humans. We employed this model to assess the consequences of a human-like BA pool on diet-induced obesity and NAFLD development. Male and female Cyp2c70-/- mice and WT littermates were challenged with a 12-week high-fat Western-type diet (WTD) supplemented with 0.25% cholesterol. Cyp2c70 deficiency induced a hydrophobic BA pool with high abundances of chenodeoxycholic acid, particularly in females, because of sex-dependent suppression of sterol 12α-hydroxylase (Cyp8b1). Plasma transaminases were elevated, and hepatic fibrosis was present in Cyp2c70-/- mice, especially in females. Surprisingly, female Cyp2c70-/- mice were resistant to WTD-induced obesity and hepatic steatosis, whereas male Cyp2c70-/- mice showed similar adiposity and moderately reduced steatosis compared with WT controls. Both intestinal cholesterol and FA absorption were reduced in Cyp2c70-/- mice, the latter more strongly in females, despite unaffected biliary BA secretion rates. Intriguingly, the biliary ratio 12α-/non-12α-hydroxylated BAs significantly correlated with FA absorption and hepatic triglyceride content as well as with specific changes in gut microbiome composition. The hydrophobic human-like BA pool in Cyp2c70-/- mice prevents WTD-induced obesity in female mice and NAFLD development in both genders, primarily because of impaired intestinal fat absorption. Our data point to a key role for 12α-hydroxylated BAs in control of intestinal fat absorption and modulation of gut microbiome composition., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
20. Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
- Author
-
Los-de Vries GT, de Boer M, van Dijk E, Stathi P, Hijmering NJ, Roemer MGM, Mendeville M, Miedema DM, de Boer JP, Rakhorst HA, van Leeuwen FE, van der Hulst RRWJ, Ylstra B, and de Jong D
- Subjects
- Female, Humans, Retrospective Studies, Breast Implants adverse effects, Breast Neoplasms etiology, Breast Neoplasms genetics, Breast Neoplasms metabolism, Breast Neoplasms pathology, Chromosome Deletion, Chromosomes, Human, Pair 20 genetics, Chromosomes, Human, Pair 20 metabolism, Lymphoma, Large-Cell, Anaplastic etiology, Lymphoma, Large-Cell, Anaplastic genetics, Lymphoma, Large-Cell, Anaplastic metabolism, Lymphoma, Large-Cell, Anaplastic pathology, Mutation, Neoplasm Proteins genetics, Neoplasm Proteins metabolism
- Abstract
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a very rare type of T-cell lymphoma that is uniquely caused by a single environmental stimulus. Here, we present a comprehensive genetic analysis of a relatively large series of BIA-ALCL (n = 29), for which genome-wide chromosomal copy number aberrations (CNAs) and mutational profiles for a subset (n = 7) were determined. For comparison, CNAs for anaplastic lymphoma kinase (ALK)- nodal anaplastic large cell lymphomas (ALCLs; n = 24) were obtained. CNAs were detected in 94% of BIA-ALCLs, with losses at chromosome 20q13.13 in 66% of the samples. Loss of 20q13.13 is characteristic of BIA-ALCL compared with other classes of ALCL, such as primary cutaneous ALCL and systemic type ALK+ and ALK- ALCL. Mutational patterns confirm that the interleukin-6-JAK1-STAT3 pathway is deregulated. Although this is commonly observed across various types of T-cell lymphomas, the extent of deregulation is significantly higher in BIA-ALCL, as indicated by phosphorylated STAT3 immunohistochemistry. The characteristic loss of chromosome 20 in BIA-ALCL provides further justification to recognize BIA-ALCL as a separate disease entity. Moreover, CNA analysis may serve as a parameter for future diagnostic assays for women with breast implants to distinguish seroma caused by BIA-ALCL from other causes of seroma accumulation, such as infection or trauma., (© 2020 by The American Society of Hematology.)
- Published
- 2020
- Full Text
- View/download PDF
21. Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast.
- Author
-
de Boer M, Hauptmann M, Hijmering NJ, van Noesel CJM, Rakhorst HA, Meijers-Heijboer HEJ, de Boer JP, van der Hulst RRWJ, de Jong D, and van Leeuwen FE
- Subjects
- Adult, Age Distribution, Aged, Female, Genetic Predisposition to Disease, Humans, Lymphoma, Large-Cell, Anaplastic epidemiology, Lymphoma, Large-Cell, Anaplastic therapy, Middle Aged, Netherlands epidemiology, Risk, Surface Properties, Time Factors, Breast Implants adverse effects, Breast Implants statistics & numerical data, Genes, BRCA1, Genes, BRCA2, Lymphoma, Large-Cell, Anaplastic genetics, Mammaplasty, Mutation, Prophylactic Mastectomy
- Published
- 2020
- Full Text
- View/download PDF
22. A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice.
- Author
-
de Boer JF, Verkade E, Mulder NL, de Vries HD, Huijkman N, Koehorst M, Boer T, Wolters JC, Bloks VW, van de Sluis B, and Kuipers F
- Subjects
- Animals, Mice, Mice, Inbred C57BL, Mice, Transgenic, Bile Acids and Salts metabolism, Cytochrome P-450 Enzyme System metabolism, Liver metabolism, Receptors, Cytoplasmic and Nuclear metabolism
- Abstract
Bile acids (BAs) facilitate intestinal absorption of lipid-soluble nutrients and modulate various metabolic pathways through the farnesoid X receptor (FXR) and Takeda G-protein-coupled receptor 5. These receptors are targets for therapy in cholestatic and metabolic diseases. However, dissimilarities in BA metabolism between humans and mice complicate translation of preclinical data. Cytochrome P450 family 2 subfamily c polypeptide 70 (CYP2C70) was recently proposed to catalyze the formation of rodent-specific muricholic acids (MCAs). With CRISPR/Cas9-mediated somatic genome editing, we generated an acute hepatic Cyp2c70 knockout mouse model ( Cyp2c70
ako ) to clarify the role of CYP2C70 in BA metabolism in vivo and evaluate whether its activity modulates effects of pharmacologic FXR activation on cholesterol homeostasis. In Cyp2c70ako mice, chenodeoxycholic acid (CDCA) increased at the expense of βMCA, resulting in a more hydrophobic human-like BA pool. Tracer studies demonstrated that, in vivo, CYP2C70 catalyzes the formation of βMCA primarily by sequential 6β-hydroxylation and C7-epimerization of CDCA, generating αMCA as an intermediate metabolite. Physiologically, the humanized BA composition in Cyp2c70ako mice blunted the stimulation of fecal cholesterol disposal in response to FXR activation compared with WT mice, predominantly due to reduced stimulation of transintestinal cholesterol excretion. Thus, deletion of hepatic Cyp2c70 in adult mice translates into a human-like BA pool composition and impacts the response to pharmacologic FXR activation. This Cyp2c70ako mouse model may be a useful tool for future studies of BA signaling and metabolism that informs human disease development and treatment., (Copyright © 2020 de Boer et al.)- Published
- 2020
- Full Text
- View/download PDF
23. Micro-scaled topographies direct differentiation of human epidermal stem cells.
- Author
-
Zijl S, Vasilevich AS, Viswanathan P, Helling AL, Beijer NRM, Walko G, Chiappini C, de Boer J, and Watt FM
- Subjects
- Humans, Keratinocytes cytology, Stem Cells cytology, Surface Properties, Cell Differentiation, Keratinocytes metabolism, Polystyrenes chemistry, Stem Cells metabolism
- Abstract
Human epidermal stem cells initiate terminal differentiation when spreading is restricted on ECM-coated micropatterned islands, soft hydrogels or hydrogel-nanoparticle composites with high nanoparticle spacing. The effect of substrate topography, however, is incompletely understood. To explore this, primary human keratinocytes enriched for stem cells were seeded on a topographical library with over 2000 different topographies in the micrometre range. Twenty-four hours later the proportion of cells expressing the differentiation marker transglutaminase-1 was determined by high content imaging. As predicted, topographies that prevented spreading promoted differentiation. However, we also identified topographies that supported differentiation of highly spread cells. Topographies supporting differentiation of spread cells were more irregular than those supporting differentiation of round cells. Low topography coverage promoted differentiation of spread cells, whereas high coverage promoted differentiation of round cells. Based on these observations we fabricated a topography in 6-well plate format that supported differentiation of spread cells, enabling us to examine cell responses at higher resolution. We found that differentiated spread cells did not assemble significant numbers of hemidesmosomes, focal adhesions, adherens junctions, desmosomes or tight junctions. They did, however, organise the actin cytoskeleton in response to the topographies. Rho kinase inhibition and blebbistatin treatment blocked the differentiation of spread cells, whereas SRF inhibition did not. These observations suggest a potential role for actin polymerization and actomyosin contraction in the topography-induced differentiation of spread cells. STATEMENT OF SIGNIFICANCE: The epidermis is the outer covering of the skin. It is formed by layers of cells called keratinocytes. The basal cell layer contains stem cells, which divide to replace cells in the outermost layers that are lost through a process known as differentiation. In this manuscript we have developed surfaces that promote the differentiation of epidermal stem cells in order to understand the signals that control differentiation. The experimental tools we have developed have the potential to help us to devise new treatments that control diseases such as psoriasis and eczema in which epidermal stem cell proliferation and differentiation are disturbed., (Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
24. Identification of topographical architectures supporting the phenotype of rat tenocytes.
- Author
-
Vermeulen S, Vasilevich A, Tsiapalis D, Roumans N, Vroemen P, Beijer NRM, Dede Eren A, Zeugolis D, and de Boer J
- Subjects
- Animals, Cell Culture Techniques, Cells, Cultured, Rats, Tendons cytology, Tenocytes cytology, Tissue Engineering, Antigens, Differentiation metabolism, Basic Helix-Loop-Helix Transcription Factors metabolism, Cell Differentiation, Tendons metabolism, Tenocytes metabolism
- Abstract
Tenocytes, the main cell type of the tendon, require mechanical stimuli for their proper function. When the tenocyte environment changes due to tissue damage or by transferring tenocytes from their native environment into cell culture, the signals from the tenocyte niche are lost, leading towards a decline of phenotypic markers. It is known that micro-topographies can influence cell fate by the physical cues they provide. To identify the optimal topography-induced biomechanical niche in vitro, we seeded tenocytes on the TopoChip, a micro-topographical screening platform, and measured expression of the tendon transcription factor Scleraxis. Through machine learning algorithms, we associated elevated Scleraxis levels with topological design parameters. Fabricating micro-topographies with optimal surface characteristics on larger surfaces allowed finding an improved expression of multiple tenogenic markers. However, long-term confluent culture conditions coincided with osteogenic marker expression and the loss of morphological characteristics. In contrast, passaging tenocytes which migrated from the tendon directly on the topography resulted in prolonged elongated morphology and elevated Scleraxis levels. This research provides new insights into how micro-topographies influence tenocyte cell fate, and supports the notion that micro-topographical design can be implemented in a new generation of tissue culture platforms for supporting the phenotype of tenocytes. STATEMENT OF SIGNIFICANCE: The challenge in controlling in vitro cell behavior lies in controlling the complex culture environment. Here, we present for the first time the use of micro-topographies as a biomechanical niche to support the phenotype of tenocytes. For this, we applied the TopoChip platform, a screening tool with 2176 unique micro-topographies for identifying feature characteristics associated with elevated Scleraxis expression, a tendon related marker. Large area fabrication of micro-topographies with favorable characteristics allowed us to find a beneficial influence on other tenogenic markers as well. Furthermore, passaging cells is more beneficial for Scleraxis marker expression and tenocyte morphology compared to confluent conditions. This study presents important insights for the understanding of tenocyte behavior in vitro, a necessary step towards tendon engineering., (Copyright © 2018. Published by Elsevier Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
25. Transmission of breast cancer by a single multiorgan donor to 4 transplant recipients.
- Author
-
Matser YAH, Terpstra ML, Nadalin S, Nossent GD, de Boer J, van Bemmel BC, van Eeden S, Budde K, Brakemeier S, and Bemelman FJ
- Subjects
- Adult, Breast Neoplasms physiopathology, Breast Neoplasms therapy, Female, Humans, Male, Middle Aged, Prognosis, Transplant Recipients, Breast Neoplasms etiology, Kidney Transplantation adverse effects, Liver Transplantation adverse effects, Lung Transplantation adverse effects, Tissue Donors
- Abstract
We report 4 cases of breast cancer transmission to transplant recipients from a single organ donor that occurred years after donation. The diagnosis of breast cancer was occult at the time of donation. All of the recipients developed a histologically similar type of breast cancer within 16 months to 6 years after transplantation. Three out of 4 recipients died as a result of widely metastasized disease. One of the recipients survived after transplant nephrectomy followed by cessation of immunosuppression and chemotherapy. This extraordinary case points out the often fatal consequences of donor-derived breast cancer and suggests that removal of the donor organ and restoration of immunity can induce complete remission., (© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.)
- Published
- 2018
- Full Text
- View/download PDF
26. Baseline peripheral blood leukocytosis: Biological marker predicts outcome in oropharyngeal cancer, regardless of HPV-status.
- Author
-
Gouw ZAR, Paul de Boer J, Navran A, van den Brekel MWM, Sonke JJ, and Al-Mamgani A
- Subjects
- Female, Humans, Male, Middle Aged, Oropharyngeal Neoplasms virology, Prognosis, Alphapapillomavirus isolation & purification, Biomarkers, Tumor blood, Leukocytosis blood, Oropharyngeal Neoplasms blood
- Abstract
Objectives: To study the prognostic value of abnormalities in baseline complete blood count in patients with oropharyngeal cancer (OPC) treated with (chemo) radiation., Methods and Materials: The prognostic value of baseline complete blood count on outcome in 234 patients with OPC treated between 2010 and 2015 was examined in multivariate analysis together with other conventional prognostic variables including HPV-status, tumor stage, tumor and nodal size., Results: The 3-year overall survival (OS), disease-free survival (DFS), locoregional control (LRC), and distant control (DC) of the whole group were 74%, 64%, 79%, and 88%, respectively. Leukocytosis and HPV-status were the only significant prognosticators for OS and DFS at the multivariate analysis. Patients without leukocytosis had a significantly better DC compared to those with leukocytosis (92% and 70%, respectively, p < 0.001). Patients with HPV-negative OPC had significantly worse LRC compared to HPV-positive patients (67% and 90%, respectively, p < 0.001). The 3-year OS in HPV-positive group with leukocytosis compared to those without leukocytosis were 69% and 95%, respectively (p < 0.001). The figures for HPV-negative patients were 41% vs. 61%, respectively (p = 0.010)., Conclusions: This is the first study to date reporting the independent impact of leukocytosis and HPV-status on outcome of patients with OPC. The poor outcome of patients with leukocytosis is mainly caused by the worse DC. The significant impact of leukocytosis on outcome was even more pronounced in HPV-positive patients. These biomarkers could help identifying patients with poor prognosis at baseline requiring intensification of local and/or systemic treatment while treatment de-intensification might be offered to the low-risk group., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
27. NanoTopoChip: High-throughput nanotopographical cell instruction.
- Author
-
Hulshof FFB, Zhao Y, Vasilevich A, Beijer NRM, de Boer M, Papenburg BJ, van Blitterswijk C, Stamatialis D, and de Boer J
- Subjects
- Bone Neoplasms pathology, Cell Culture Techniques methods, Cell Line, Tumor, Humans, Osteosarcoma pathology, Bone Neoplasms metabolism, Cell Culture Techniques instrumentation, Lab-On-A-Chip Devices, Osteosarcoma metabolism
- Abstract
Surface topography is able to influence cell phenotype in numerous ways and offers opportunities to manipulate cells and tissues. In this work, we develop the Nano-TopoChip and study the cell instructive effects of nanoscale topographies. A combination of deep UV projection lithography and conventional lithography was used to fabricate a library of more than 1200 different defined nanotopographies. To illustrate the cell instructive effects of nanotopography, actin-RFP labeled U2OS osteosarcoma cells were cultured and imaged on the Nano-TopoChip. Automated image analysis shows that of many cell morphological parameters, cell spreading, cell orientation and actin morphology are mostly affected by the nanotopographies. Additionally, by using modeling, the changes of cell morphological parameters could by predicted by several feature shape parameters such as lateral size and spacing. This work overcomes the technological challenges of fabricating high quality defined nanoscale features on unprecedented large surface areas of a material relevant for tissue culture such as PS and the screening system is able to infer nanotopography - cell morphological parameter relationships. Our screening platform provides opportunities to identify and study the effect of nanotopography with beneficial properties for the culture of various cell types., Statement of Significance: The nanotopography of biomaterial surfaces can be modified to influence adhering cells with the aim to improve the performance of medical implants and tissue culture substrates. However, the necessary knowledge of the underlying mechanisms remains incomplete. One reason for this is the limited availability of high-resolution nanotopographies on relevant biomaterials, suitable to conduct systematic biological studies. The present study shows the fabrication of a library of nano-sized surface topographies with high fidelity. The potential of this library, called the 'NanoTopoChip' is shown in a proof of principle HTS study which demonstrates how cells are affected by nanotopographies. The large dataset, acquired by quantitative high-content imaging, allowed us to use predictive modeling to describe how feature dimensions affect cell morphology., (Copyright © 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
28. High-definition micropatterning method for hard, stiff and brittle polymers.
- Author
-
Zhao Y, Truckenmuller R, Levers M, Hua WS, de Boer J, and Papenburg B
- Subjects
- Cell Culture Techniques methods, Cell Culture Techniques instrumentation, Elastic Modulus, Polystyrenes chemistry, Ultraviolet Rays
- Abstract
Polystyrene (PS) is the most commonly used material in cell culture devices, such as Petri dishes, culture flasks and well plates. Micropatterning of cell culture substrates can significantly affect cell-material interactions leading to an increasing interest in the fabrication of topographically micro-structured PS surfaces. However, the high stiffness combined with brittleness of PS (elastic modulus 3-3.5GPa) makes high-quality patterning into PS difficult when standard hard molds, e.g. silicon and nickel, are used as templates. A new and robust scheme for easy processing of large-area high-density micro-patterning into PS film is established using nanoimprinting lithography and standard hot embossing techniques. Including an extra step through an intermediate PDMS mold alone does not result in faithful replication of the large area, high-density micropattern into PS. Here, we developed an approach using an additional intermediate mold out of OrmoStamp, which allows for high-quality and large-area micro-patterning into PS. OrmoStamp was originally developed for UV nanoimprint applications; this work demonstrates for the first time that OrmoStamp is a highly adequate material for micro-patterning of PS through hot embossing. Our proposed processing method achieves high-quality replication of micropatterns in PS, incorporating features with high aspect ratio (4:1, height:width), high density, and over a large pattern area. The proposed scheme can easily be adapted for other large-area and high-density micropatterns of PS, as well as other stiff and brittle polymers., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
29. HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels.
- Author
-
Annema W, Willemsen HM, de Boer JF, Dikkers A, van der Giet M, Nieuwland W, Muller Kobold AC, van Pelt LJ, Slart RH, van der Horst IC, Dullaart RP, Tio RA, and Tietge UJ
- Subjects
- Acute Disease, Adult, Aged, Amine Oxidase (Copper-Containing) metabolism, C-Reactive Protein analysis, Cell Adhesion Molecules metabolism, Creatine Kinase blood, Creatine Kinase, MB Form blood, Female, Follow-Up Studies, Gene Expression drug effects, Human Umbilical Vein Endothelial Cells, Humans, Linear Models, Macrophages metabolism, Male, Middle Aged, Prospective Studies, Tumor Necrosis Factor-alpha pharmacology, Cholesterol, HDL blood, Myocardial Infarction diagnosis
- Abstract
Background: High-density lipoproteins (HDLs) protect against the development of atherosclerotic cardiovascular disease. HDL function represents an emerging concept in cardiovascular research., Objective: This study investigated the association between HDL functionality and acute myocardial infarction (MI) independent of HDL-cholesterol plasma levels., Methods: Participants (non-ST-segment elevation MI, non-STEMI, n = 41; STEMI, n = 37; non-MI patients, n = 33) from a prospective follow-up study enrolling patients with acute chest pain were matched for age and plasma HDL cholesterol. The in vitro capacity of HDL to (1) mediate cholesterol efflux from macrophage foam cells, (2) prevent low-density lipoprotein oxidation, and (3) inhibit TNF-α-induced vascular adhesion molecule-1 expression in endothelial cells was determined., Results: STEMI-HDL displayed reduced cholesterol efflux (P < .001) and anti-inflammatory functionality (P = .001), whereas the antioxidative properties were unaltered. Cholesterol efflux correlated with the anti-inflammatory HDL activity (P < .001). Not C-reactive protein levels, a marker of systemic inflammation, but specifically plasma myeloperoxidase levels were independently associated with impaired HDL function (efflux: P = .022; anti-inflammation: P < .001). Subjects in the higher risk quartile of efflux (odds ratio [OR], 5.66; 95% confidence interval [CI], 1.26-25.00; P = .024) as well as anti-inflammatory functionality of HDL (OR, 5.53; 95% CI, 1.83-16.73; P = .002) had a higher OR for MI vs those in the three lower risk quartiles combined., Conclusion: Independent of plasma HDL cholesterol levels, 2 of 3 antiatherogenic HDL functionalities tested were significantly impaired in STEMI patients, namely cholesterol efflux and anti-inflammatory properties. Increased myeloperoxidase levels might represent a major contributing mechanism for decreased HDL functionality in MI patients., (Copyright © 2016 National Lipid Association. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
30. Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice.
- Author
-
Schonewille M, de Boer JF, Mele L, Wolters H, Bloks VW, Wolters JC, Kuivenhoven JA, Tietge UJ, Brufau G, and Groen AK
- Subjects
- Animals, Cholesterol blood, Drug Evaluation, Preclinical, Gene Expression drug effects, Glutarates metabolism, Hypercholesterolemia blood, Hypercholesterolemia drug therapy, Intestinal Elimination drug effects, Intestine, Small drug effects, Intestine, Small metabolism, Liver drug effects, Male, Mice, Inbred C57BL, Cholesterol biosynthesis, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Liver metabolism, Lovastatin pharmacology
- Abstract
Statins are competitive inhibitors of HMG-CoA reductase, the rate-limiting enzyme of cholesterol synthesis. Statins reduce plasma cholesterol levels, but whether this is actually caused by inhibition of de novo cholesterol synthesis has not been clearly established. Using three different statins, we investigated the effects on cholesterol metabolism in mice in detail. Surprisingly, direct measurement of whole body cholesterol synthesis revealed that cholesterol synthesis was robustly increased in statin-treated mice. Measurement of organ-specific cholesterol synthesis demonstrated that the liver is predominantly responsible for the increase in cholesterol synthesis. Excess synthesized cholesterol did not accumulate in the plasma, as plasma cholesterol decreased. However, statin treatment led to an increase in cholesterol removal via the feces. Interestingly, enhanced cholesterol excretion in response to rosuvastatin and lovastatin treatment was mainly mediated via biliary cholesterol secretion, whereas atorvastatin mainly stimulated cholesterol removal via the transintestinal cholesterol excretion pathway. Moreover, we show that plasma cholesterol precursor levels do not reflect cholesterol synthesis rates during statin treatment in mice. In conclusion, cholesterol synthesis is paradoxically increased upon statin treatment in mice. However, statins potently stimulate the excretion of cholesterol from the body, which sheds new light on possible mechanisms underlying the cholesterol-lowering effects of statins., (Copyright © 2016 by the American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
31. Stimulatory effect of cobalt ions incorporated into calcium phosphate coatings on neovascularization in an in vivo intramuscular model in goats.
- Author
-
Tahmasebi Birgani Z, Fennema E, Gijbels MJ, de Boer J, van Blitterswijk CA, and Habibovic P
- Subjects
- Administration, Intranasal, Animals, Cations, Divalent chemistry, Cations, Divalent pharmacology, Goats, Bone Substitutes chemistry, Bone Substitutes pharmacology, Calcium Phosphates chemistry, Calcium Phosphates pharmacology, Coated Materials, Biocompatible chemistry, Coated Materials, Biocompatible pharmacology, Cobalt chemistry, Cobalt pharmacology, Neovascularization, Physiologic
- Abstract
Unlabelled: Rapid vascularization of bone graft substitutes upon implantation is one of the most important challenges to overcome in order to achieve successful regeneration of large, critical-size bone defects. One strategy for stimulating vascularization during the regeneration process is to create a hypoxic microenvironment by either directly lowering the local oxygen tension, or by applying hypoxia-mimicking factors. Cells compensate for the hypoxic condition by releasing angiogenic factors leading to new blood vessel formation. In the present study, we explored the potential of cobalt ions (Co(2+)), known chemical mimickers of hypoxia, to stimulate vascularization within a bone graft substitute in vivo. To this end, Co(2+) ions were incorporated into calcium phosphate (CaPs) coatings deposited on poly(lactic acid) (PLA) particles with their effect on the formation of new blood vessels studied upon intramuscular implantation in goats. PLA particles and CaP-coated particles without Co(2+) ions served as controls. Pathological scoring of the inflammatory response following a 12-week implantation period showed no significant differences between the four types of materials. Based on histological and immunohistochemical analyses, both blood vessel area and number of blood vessels in CaP-coated PLA particles containing Co(2+) were higher than in the uncoated PLA particles and CaP-coated PLA particles without Co(2+). Analysis of blood vessel size distribution indicated abundant formation of small blood vessels in all the samples, while large blood vessels were predominantly found in PLA particles coated with CaP containing Co(2+) ions. The results of this study support the use of CaPs containing Co(2+) ions to enhance vascularization in vivo., Statement of Significance: In this work, we have investigated the potential of cobalt ions, incorporated into thin calcium phosphate (CaP) coatings that were deposited on particles of poly(lactic acid) (PLA), to induce neovascularization in vivo. Qualitative and quantitative histological and immunohistochemical analyses showed that both the number of blood vessels and the total blood vessel area were higher in CaP-coated PLA particles containing cobalt ions as compared to the uncoated PLA particles and CaP-coated PLA particles without the metallic additive. Furthermore, a wider distribution of blood vessel sizes, varying from very small to large vessels was specifically observed in samples containing cobalt ions. This in vivo study will significantly contribute to the existing knowledge on the use of bioinorganics, which are simple and inexpensive inorganic factors that can be used to control relevant biological process during tissue regeneration, such as vascularization. As such, we are convinced that this manuscript will be of interest to the readers of Acta Biomaterialia., (Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
32. A relativity concept in mesenchymal stromal cell manufacturing.
- Author
-
Martin I, De Boer J, and Sensebe L
- Subjects
- Cellular Senescence physiology, Female, Humans, Middle Aged, Cell Culture Techniques, Cell- and Tissue-Based Therapy methods, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells cytology
- Abstract
Mesenchymal stromal cells (MSCs) are being experimentally tested in several biological systems and clinical settings with the aim of verifying possible therapeutic effects for a variety of indications. MSCs are also known to be heterogeneous populations, with phenotypic and functional features that depend heavily on the individual donor, the harvest site, and the culture conditions. In the context of this multidimensional complexity, a recurrent question is whether it is feasible to produce MSC batches as "standard" therapeutics, possibly within scalable manufacturing systems. Here, we provide a short overview of the literature on different culture methods for MSCs, including those employing innovative technologies, and of some typically assessed functional features (e.g., growth, senescence, genomic stability, clonogenicity, etc.). We then offer our perspective of a roadmap on how to identify and refine manufacturing systems for MSCs intended for specific clinical indications. We submit that the vision of producing MSCs according to a unique standard, although commercially attractive, cannot yet be scientifically substantiated. Instead, efforts should be concentrated on standardizing methods for characterization of MSCs generated by different groups, possibly covering a vast gamut of functionalities. Such assessments, combined with hypotheses on the therapeutic mode of action and associated clinical data, should ultimately allow definition of in-process controls and measurable release criteria for MSC manufacturing. These will have to be validated as predictive of potency in suitable pre-clinical models and of therapeutic efficacy in patients., (Copyright © 2016 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
33. Stepping into the omics era: Opportunities and challenges for biomaterials science and engineering.
- Author
-
Groen N, Guvendiren M, Rabitz H, Welsh WJ, Kohn J, and de Boer J
- Subjects
- Animals, Biocompatible Materials chemistry, Biocompatible Materials pharmacology, Combinatorial Chemistry Techniques, Humans, Biocompatible Materials chemical synthesis, Genomics methods, Materials Testing methods
- Abstract
The research paradigm in biomaterials science and engineering is evolving from using low-throughput and iterative experimental designs towards high-throughput experimental designs for materials optimization and the evaluation of materials properties. Computational science plays an important role in this transition. With the emergence of the omics approach in the biomaterials field, referred to as materiomics, high-throughput approaches hold the promise of tackling the complexity of materials and understanding correlations between material properties and their effects on complex biological systems. The intrinsic complexity of biological systems is an important factor that is often oversimplified when characterizing biological responses to materials and establishing property-activity relationships. Indeed, in vitro tests designed to predict in vivo performance of a given biomaterial are largely lacking as we are not able to capture the biological complexity of whole tissues in an in vitro model. In this opinion paper, we explain how we reached our opinion that converging genomics and materiomics into a new field would enable a significant acceleration of the development of new and improved medical devices. The use of computational modeling to correlate high-throughput gene expression profiling with high throughput combinatorial material design strategies would add power to the analysis of biological effects induced by material properties. We believe that this extra layer of complexity on top of high-throughput material experimentation is necessary to tackle the biological complexity and further advance the biomaterials field., Statement of Significance: In this opinion paper, we postulate that converging genomics and materiomics into a new field would enable a significant acceleration of the development of new and improved medical devices. The use of computational modeling to correlate high-throughput gene expression profiling with high throughput combinatorial material design strategies would add power to the analysis of biological effects induced by material properties. We believe that this extra layer of complexity on top of high-throughput material experimentation is necessary to tackle the biological complexity and further advance the biomaterials field., (Copyright © 2016. Published by Elsevier Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
34. Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT.
- Author
-
Dikkers A, de Boer JF, Groen AK, and Tietge UJ
- Subjects
- ATP Binding Cassette Transporter, Subfamily G, Member 5, ATP Binding Cassette Transporter, Subfamily G, Member 8, ATP-Binding Cassette Transporters deficiency, ATP-Binding Cassette Transporters genetics, Animals, Cholesterol blood, Gene Transfer Techniques, Genotype, Lipoproteins deficiency, Lipoproteins genetics, Mice, Inbred C57BL, Mice, Knockout, Phenotype, Up-Regulation, ATP-Binding Cassette Transporters metabolism, Bile metabolism, Cholesterol metabolism, Feces chemistry, Hepatobiliary Elimination, Lipoproteins metabolism, Liver metabolism, Macrophages metabolism
- Abstract
Background and Aims: Biliary cholesterol secretion is important for reverse cholesterol transport (RCT). ABCG5/G8 contribute most cholesterol mass secretion into bile. We investigated the impact of hepatic ABCG5/G8 on cholesterol metabolism and RCT., Methods: Biliary and fecal sterol excretion (FSE) as well as RCT were determined using wild-type controls, Abcg8 knockout mice, Abcg8 knockouts with adenovirus-mediated hepatocyte-specific Abcg8 reinstitution and hepatic Abcg5/g8 overexpression in wild-types., Results: In Abcg8 knockouts, biliary cholesterol secretion was decreased by 75% (p < 0.001), while mass FSE and RCT were unchanged. Hepatic reinstitution of Abcg8 increased biliary cholesterol secretion 5-fold (p < 0.001) without changing FSE or overall RCT. Overexpression of both ABCG5/G8 elevated biliary cholesterol secretion 5-fold and doubled FSE (p < 0.001) without affecting overall RCT., Conclusions: ABCG5/G8 mediate mass biliary cholesterol secretion but not from a RCT-relevant pool. Intervention strategies aiming at increasing hepatic Abcg5/g8 expression for enhancing RCT are not likely to be successful., (Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
35. Analysis of high-throughput screening reveals the effect of surface topographies on cellular morphology.
- Author
-
Hulsman M, Hulshof F, Unadkat H, Papenburg BJ, Stamatialis DF, Truckenmüller R, van Blitterswijk C, de Boer J, and Reinders MJ
- Subjects
- Cell Nucleus Shape, Computer Simulation, Humans, Surface Properties, Cell Shape, High-Throughput Screening Assays methods, Mesenchymal Stem Cells cytology
- Abstract
Surface topographies of materials considerably impact cellular behavior as they have been shown to affect cell growth, provide cell guidance, and even induce cell differentiation. Consequently, for successful application in tissue engineering, the contact interface of biomaterials needs to be optimized to induce the required cell behavior. However, a rational design of biomaterial surfaces is severely hampered because knowledge is lacking on the underlying biological mechanisms. Therefore, we previously developed a high-throughput screening device (TopoChip) that measures cell responses to large libraries of parameterized topographical material surfaces. Here, we introduce a computational analysis of high-throughput materiome data to capture the relationship between the surface topographies of materials and cellular morphology. We apply robust statistical techniques to find surface topographies that best promote a certain specified cellular response. By augmenting surface screening with data-driven modeling, we determine which properties of the surface topographies influence the morphological properties of the cells. With this information, we build models that predict the cellular response to surface topographies that have not yet been measured. We analyze cellular morphology on 2176 surfaces, and find that the surface topography significantly affects various cellular properties, including the roundness and size of the nucleus, as well as the perimeter and orientation of the cells. Our learned models capture and accurately predict these relationships and reveal a spectrum of topographies that induce various levels of cellular morphologies. Taken together, this novel approach of high-throughput screening of materials and subsequent analysis opens up possibilities for a rational design of biomaterial surfaces., (Copyright © 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
36. Risk of multiple primary malignancies following treatment of Hodgkin lymphoma.
- Author
-
van Eggermond AM, Schaapveld M, Lugtenburg PJ, Krol AD, de Boer JP, Zijlstra JM, Raemaekers JM, Kremer LC, Roesink JM, Louwman MW, Aleman BM, and van Leeuwen FE
- Subjects
- Adult, Age Factors, Cohort Studies, Education, Medical, Continuing, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Neoplasms, Second Primary epidemiology, Neoplasms, Second Primary therapy, Netherlands epidemiology, Risk Factors, Young Adult, Hodgkin Disease therapy, Neoplasms, Second Primary etiology
- Abstract
We assessed risk, localization, and timing of third malignancies in Hodgkin lymphoma (HL) survivors. In a cohort of 3122 5-year HL survivors diagnosed before the age of 51 years and treated between 1965 and 1995, we examined whether risk factors for second and third malignancies differ and whether the occurrence of a second malignancy affects the risk of subsequent malignancies, using recurrent event analyses. After a median follow-up of 22.6 years, 832 patients developed a second malignancy and 126 patients a third one. The risk of a second malignancy was 4.7-fold increased (95% confidence interval [CI], 4.4-5.1) compared with risk in the general population; the risk for a third malignancy after a second malignancy was 5.4-fold (95% CI, 4.4-6.5) increased. The 10-year cumulative incidence of any third malignancy was 13.3%. Compared with patients still free of a second malignancy, patients with a second malignancy had a higher risk of developing subsequent malignancies. This risk depended on age, with hazard ratios of 2.2, 1.6, and 1.1 for patients aged <25, 25 to 34, and 35 to 50 years at HL treatment, respectively. In HL survivors who had a second malignancy, treating physicians should be aware of the increased risk of subsequent malignancies., (© 2014 by The American Society of Hematology.)
- Published
- 2014
- Full Text
- View/download PDF
37. Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice.
- Author
-
Dikkers A, Annema W, de Boer JF, Iqbal J, Hussain MM, and Tietge UJ
- Subjects
- Animals, Apolipoproteins B biosynthesis, Benzimidazoles pharmacology, Biliary Tract drug effects, Biliary Tract metabolism, Biological Transport drug effects, Carrier Proteins genetics, Feces chemistry, Fluorenes pharmacology, Gene Knockout Techniques, Hepatocytes drug effects, Hepatocytes metabolism, Intestinal Absorption drug effects, Intestinal Mucosa metabolism, Intestines drug effects, Liver cytology, Macrophages drug effects, Macrophages metabolism, Mice, Organ Specificity, Triglycerides blood, Carrier Proteins antagonists & inhibitors, Carrier Proteins metabolism, Cholesterol metabolism, Liver metabolism
- Abstract
Because apoB-containing lipoproteins are pro-atherogenic and their secretion by liver and intestine largely depends on microsomal triglyceride transfer protein (MTP) activity, MTP inhibition strategies are actively pursued. How decreasing the secretion of apoB-containing lipoproteins affects intracellular rerouting of cholesterol is unclear. Therefore, the aim of the present study was to determine the effects of reducing either systemic or liver-specific MTP activity on cholesterol metabolism and reverse cholesterol transport (RCT) using a pharmacological MTP inhibitor or a genetic model, respectively. Plasma total cholesterol and triglyceride levels were decreased in both MTP inhibitor-treated and liver-specific MTP knockout (L-Mttp(-/-)) mice (each P < 0.001). With both inhibition approaches, hepatic cholesterol as well as triglyceride content was consistently increased (each P < 0.001), while biliary cholesterol and bile acid secretion remained unchanged. A small but significant decrease in fecal bile acid excretion was observed in inhibitor-treated mice (P < 0.05), whereas fecal neutral sterol excretion was substantially increased by 75% (P < 0.001), conceivably due to decreased intestinal absorption. In contrast, in L-Mttp(-/-) mice both fecal neutral sterol and bile acid excretion remained unchanged. However, while total RCT increased in inhibitor-treated mice (P < 0.01), it surprisingly decreased in L-Mttp(-/-) mice (P < 0.05). These data demonstrate that: i) pharmacological MTP inhibition increases RCT, an effect that might provide additional clinical benefit of MTP inhibitors; and ii) decreasing hepatic MTP decreases RCT, pointing toward a potential contribution of hepatocyte-derived VLDLs to RCT.
- Published
- 2014
- Full Text
- View/download PDF
38. Surface modifications by gas plasma control osteogenic differentiation of MC3T3-E1 cells.
- Author
-
Barradas AM, Lachmann K, Hlawacek G, Frielink C, Truckenmoller R, Boerman OC, van Gastel R, Garritsen H, Thomas M, Moroni L, van Blitterswijk C, and de Boer J
- Subjects
- Adsorption drug effects, Animals, Atmospheric Pressure, Biocompatible Materials pharmacology, Cell Adhesion drug effects, Cell Line, Cell Proliferation drug effects, Gene Expression Regulation drug effects, Hydrophobic and Hydrophilic Interactions drug effects, Lactic Acid pharmacology, Mice, Microscopy, Atomic Force, Osteoblasts metabolism, Polyesters, Polymers pharmacology, Serum Albumin, Bovine metabolism, Surface Properties drug effects, Cell Differentiation drug effects, Osteoblasts cytology, Osteoblasts drug effects, Osteogenesis drug effects, Plasma Gases pharmacology
- Abstract
Numerous studies have shown that the physicochemical properties of biomaterials can control cell activity. Cell adhesion, proliferation, differentiation as well as tissue formation in vivo can be tuned by properties such as the porosity, surface micro- and nanoscale topography and chemical composition of biomaterials. This concept is very appealing for tissue engineering since instructive properties in bioactive materials can be more economical and time efficient than traditional strategies of cell pre-differentiation in vitro prior to implantation. The biomaterial surface, which is easy to modify due to its accessibility, may provide the necessary signals to elicit a certain cellular behavior. Here, we used gas plasma technology at atmospheric pressure to modify the physicochemical properties of polylactic acid and analyzed how this influenced pre-osteoblast proliferation and differentiation. Tetramethylsilane and 3-aminopropyl-trimethoxysilane with helium as a carrier gas or a mixture of nitrogen and hydrogen were discharged to polylactic acid discs to create different surface chemical compositions, hydrophobicity and microscale topographies. Such modifications influenced protein adsorption and pre-osteoblast cell adhesion, proliferation and osteogenic differentiation. Furthermore polylactic acid treated with tetramethylsilane enhanced osteogenic differentiation compared to the other surfaces. This promising surface modification could be further explored for potential development of bone graft substitutes., (Copyright © 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
39. Pancreatic β-cell function relates positively to HDL functionality in well-controlled type 2 diabetes mellitus.
- Author
-
Dullaart RP, Annema W, de Boer JF, and Tietge UJ
- Subjects
- Adult, Aged, Analysis of Variance, Biomarkers blood, Blood Glucose drug effects, Cells, Cultured, Chi-Square Distribution, Cholesterol blood, Diabetes Mellitus, Type 2 drug therapy, Diabetes Mellitus, Type 2 physiopathology, Female, Fibroblasts metabolism, Glycated Hemoglobin metabolism, Homeostasis, Humans, Hypoglycemic Agents therapeutic use, Insulin blood, Insulin-Secreting Cells drug effects, Linear Models, Male, Middle Aged, Netherlands, Oxidation-Reduction, Blood Glucose metabolism, Diabetes Mellitus, Type 2 blood, Insulin-Secreting Cells metabolism, Lipoproteins, HDL blood
- Abstract
Background: High density lipoproteins (HDLs) have been implicated in glucose homeostasis. Among subjects with normal fasting glucose (NFG), impaired fasting glucose (IFG) and Type 2 diabetes mellitus (T2DM) we tested whether pancreatic β-cell function relates to HDL functionality, as determined by HDL anti-oxidative capacity and cellular cholesterol efflux to plasma., Subjects and Methods: HDL anti-oxidative capacity (inhibition of LDL oxidation in vitro), cellular cholesterol efflux (the ability of plasma to stimulate cholesterol efflux out of cultured fibroblasts obtained from a single human donor), glucose and insulin were determined in fasting plasma samples from 37 subjects with NFG, 36 with IFG and 22 with T2DM (no glucose lowering drug or insulin treatment; HbA1c 6.0±1.0%). Homeostasis model assessment was used to estimate pancreatic β-cell function (HOMA-β) and insulin resistance (HOMAir)., Results: HOMA-β was lowest, whereas HOMAir was highest in T2DM (P<0.01 and P<0.001 vs. NFG). HDL anti-oxidative capacity and cellular cholesterol efflux did not differ significantly according to glucose tolerance category. In univariate analysis and after controlling for HOMAir both HDL anti-oxidative capacity (P<0.05) and cellular cholesterol efflux (P<0.01) were positively correlated with HOMA-β in T2DM, but not in NFG and IFG. In age-, sex- and HOMAir-adjusted analyses, T2DM status interacted positively with HDL anti-oxidative capacity (P=0.001) and cellular cholesterol efflux (P=0.042) on HOMA-β. HbA1c interacted similarly with HDL functionality measures on HOMA-β., Conclusions: Pancreatic β-cell function relates to pathophysiologically relevant measures of HDL function in T2DM, but not in NFG and IFG. Better HDL functionality may contribute to maintenance of β-cell function in subjects with well-controlled T2DM., (Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
40. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma.
- Author
-
Annema W, Dikkers A, Freark de Boer J, Gautier T, Rensen PCN, Rader DJ, and Tietge UJF
- Subjects
- ATP Binding Cassette Transporter 1, Animals, Apolipoprotein E3 genetics, Biliary Tract drug effects, Biliary Tract metabolism, Biological Transport drug effects, CD36 Antigens metabolism, Cholesterol, HDL chemistry, Feces, Hepatocytes drug effects, Hepatocytes metabolism, Humans, Liver cytology, Liver drug effects, Macrophages drug effects, Macrophages metabolism, Mice, Mice, Inbred C57BL, Particle Size, Probucol pharmacology, ATP-Binding Cassette Transporters metabolism, Apolipoprotein E3 metabolism, Cholesterol blood, Cholesterol metabolism, Cholesterol, HDL metabolism, Liver metabolism
- Abstract
ApoE plays an important role in lipoprotein metabolism. This study investigated the effects of adenovirus-mediated human apoE overexpression (AdhApoE3) on sterol metabolism and in vivo reverse cholesterol transport (RCT). In wild-type mice, AdhApoE3 resulted in decreased HDL cholesterol levels and a shift toward larger HDL in plasma, whereas hepatic cholesterol content increased (P < 0.05). These effects were dependent on scavenger receptor class B type I (SR-BI) as confirmed using SR-BI-deficient mice. Kinetic studies demonstrated increased plasma HDL cholesteryl ester catabolic rates (P < 0.05) and higher hepatic selective uptake of HDL cholesteryl esters in AdhApoE3-injected wild-type mice (P < 0.01). However, biliary and fecal sterol output as well as in vivo macrophage-to-feces RCT studied with (3)H-cholesterol-loaded mouse macrophage foam cells remained unchanged upon human apoE overexpression. Similar results were obtained using hApoE3 overexpression in human CETP transgenic mice. However, blocking ABCA1-mediated cholesterol efflux from hepatocytes in AdhApoE3-injected mice using probucol increased biliary cholesterol secretion (P < 0.05), fecal neutral sterol excretion (P < 0.05), and in vivo RCT (P < 0.01), specifically within neutral sterols. These combined data demonstrate that systemic apoE overexpression increases i) SR-BI-mediated selective uptake into the liver and ii) ABCA1-mediated efflux of RCT-relevant cholesterol from hepatocytes back to the plasma compartment, thereby resulting in unchanged fecal mass sterol excretion and overall in vivo RCT.
- Published
- 2012
- Full Text
- View/download PDF
41. Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice.
- Author
-
Freark de Boer J, Annema W, Schreurs M, van der Veen JN, van der Giet M, Nijstad N, Kuipers F, and Tietge UJF
- Subjects
- Animals, Cardiovascular Diseases, Cholesterol blood, Diabetes Mellitus, Experimental blood, Diabetes Mellitus, Experimental metabolism, Diabetes Mellitus, Type 1 metabolism, Fatty Acids, Nonesterified blood, Lipoproteins blood, Liver metabolism, Mice, Mice, Inbred C57BL, Models, Biological, Phospholipids blood, Phospholipids metabolism, Real-Time Polymerase Chain Reaction, Bile Acids and Salts metabolism, Biological Transport physiology, Cholesterol metabolism, Diabetes Mellitus, Type 1 blood, Feces chemistry, Macrophages metabolism
- Abstract
Type I diabetes mellitus (T1DM) increases atherosclerotic cardiovascular disease; however, the underlying pathophysiology is still incompletely understood. We investigated whether experimental T1DM impacts HDL-mediated reverse cholesterol transport (RCT). C57BL/6J mice with alloxan-induced T1DM had higher plasma cholesterol levels (P < 0.05), particularly within HDL, and increased hepatic cholesterol content (P < 0.001). T1DM resulted in increased bile flow (2.1-fold; P < 0.05) and biliary secretion of bile acids (BA, 10.5-fold; P < 0.001), phospholipids (4.5-fold; P < 0.001), and cholesterol (5.5-fold; P < 0.05). Hepatic cholesterol synthesis was unaltered, whereas BA synthesis was increased in T1DM (P < 0.001). Mass fecal BA output was significantly higher in T1DM mice (1.5-fold; P < 0.05), fecal neutral sterol excretion did not change due to increased intestinal cholesterol absorption (2.1-fold; P < 0.05). Overall in vivo macrophage-to-feces RCT, using [(3)H]cholesterol-loaded primary mouse macrophage foam cells, was 20% lower in T1DM (P < 0.05), mainly due to reduced tracer excretion within BA (P < 0.05). In vitro experiments revealed unchanged cholesterol efflux toward T1DM HDL, whereas scavenger receptor class BI-mediated selective uptake from T1DM HDL was lower in vitro and in vivo (HDL kinetic experiments) (P < 0.05), conceivably due to increased glycation of HDL-associated proteins (+65%, P < 0.01). In summary, despite higher mass biliary sterol secretion T1DM impairs macrophage-to-feces RCT, mainly by decreasing hepatic selective uptake, a mechanism conceivably contributing to increased cardiovascular disease in T1DM.
- Published
- 2012
- Full Text
- View/download PDF
42. Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus.
- Author
-
Mulder DJ, de Boer JF, Graaff R, de Vries R, Annema W, Lefrandt JD, Smit AJ, Tietge UJ, and Dullaart RP
- Subjects
- Aged, Antioxidants chemistry, Antioxidants metabolism, Cross-Sectional Studies, Diabetes Complications metabolism, Female, Fluorescence, Glycation End Products, Advanced metabolism, Humans, Insulin Resistance, Male, Middle Aged, Oxidative Stress, Spectrometry, Fluorescence methods, Triglycerides metabolism, Diabetes Mellitus, Type 2 blood, Lipoproteins, HDL chemistry, Skin pathology
- Abstract
Objective: High density lipoprotein (HDL) particles protect apolipoprotein B-containing lipoproteins from oxidative modification. An impaired anti-oxidative functionality of HDL in type 2 diabetes mellitus (T2DM) may contribute to enhanced formation of oxidative stress products, such as Advanced Glycation Endproducts (AGEs). We tested whether in T2DM the HDL anti-oxidative capacity is related to the accumulation of AGEs in the skin., Methods: Skin autofluorescence (AF), a non-invasive read-out for AGEs, and HDL anti-oxidative capacity, i.e. the ability of HDL to protect against LDL oxidation in vitro, were assessed in 67 non-smoking T2DM patients without complications (median age: 60 (53-65), 60% males, 6.5 (5.2-8.5) years of diabetes duration)., Results: In univariate analysis, skin AF correlated inversely with HDL anti-oxidative capacity (r=-0.305, P<0.02), but not with HDL cholesterol or apolipoprotein A-I. HDL anti-oxidative capacity correlated inversely with glucose, HbA(1c), triglycerides, and insulin resistance (homeostasis model assessment) (P<0.05 to P ≤ 0.001). Multiple linear regression showed that skin AF remained inversely related to HDL anti-oxidative capacity (partial r=-0.314, P=0.015) taking account of age, plasma glucose, non-HDL cholesterol, triglycerides, HOMA(ir), and CRP., Conclusion: These findings suggest that skin AF is inversely related to the HDL anti-oxidative capacity rather than to the HDL cholesterol concentration in T2DM. Impaired anti-oxidative functionality of HDL could contribute to tissue accumulation of AGEs., (Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
43. Surgical debulking combined with photodynamic therapy to manage residual extramedullary plasmacytoma of the nasopharynx.
- Author
-
Karakullukcu B, De Boer JP, Van Veen R, Wegman J, and Tan B
- Subjects
- Disease-Free Survival, Endoscopy methods, Follow-Up Studies, Humans, Male, Mesoporphyrins therapeutic use, Middle Aged, Nasopharyngeal Neoplasms drug therapy, Nasopharyngeal Neoplasms radiotherapy, Neoplasm, Residual drug therapy, Photosensitizing Agents therapeutic use, Plasmacytoma drug therapy, Plasmacytoma radiotherapy, Radiotherapy Dosage, Remission Induction, Nasopharyngeal Neoplasms surgery, Neoadjuvant Therapy, Photochemotherapy methods, Plasmacytoma surgery
- Abstract
Extramedullary plasmacytomas (EMP) are rare plasma cell neoplasms that are mostly located in the mucosal surfaces of the upper aerodigestive tract. The standard treatment is radiotherapy (RT), with surgical resection reserved as salvage procedure. In this report a patient with a EMP, located in the nasopharynx and refractory to curative RT. Because of the technical difficulty of a radical resection in the nasopharynx area the EMP is managed by endoscopic debulking and temoporfin mediated photodynamic therapy. The patient remains disease free since six years., (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
44. Effects of the architecture of tissue engineering scaffolds on cell seeding and culturing.
- Author
-
Melchels FP, Barradas AM, van Blitterswijk CA, de Boer J, Feijen J, and Grijpma DW
- Subjects
- Animals, Cells, Cultured, Luciferases metabolism, Methylene Blue, Porosity, Staining and Labeling, Stromal Cells cytology, Stromal Cells metabolism, X-Ray Microtomography, Cell Culture Techniques methods, Mesoderm cytology, Tissue Engineering methods, Tissue Scaffolds chemistry
- Abstract
The advance of rapid prototyping techniques has significantly improved control over the pore network architecture of tissue engineering scaffolds. In this work, we have assessed the influence of scaffold pore architecture on cell seeding and static culturing, by comparing a computer designed gyroid architecture fabricated by stereolithography with a random pore architecture resulting from salt leaching. The scaffold types showed comparable porosity and pore size values, but the gyroid type showed a more than 10-fold higher permeability due to the absence of size-limiting pore interconnections. The higher permeability significantly improved the wetting properties of the hydrophobic scaffolds and increased the settling speed of cells upon static seeding of immortalised mesenchymal stem cells. After dynamic seeding followed by 5 days of static culture gyroid scaffolds showed large cell populations in the centre of the scaffold, while salt-leached scaffolds were covered with a cell sheet on the outside and no cells were found in the scaffold centre. It was shown that interconnectivity of the pores and permeability of the scaffold prolonged the time of static culture before overgrowth of cells at the scaffold periphery occurred. Furthermore, novel scaffold designs are proposed to further improve the transport of oxygen and nutrients throughout the scaffolds and to create tissue engineering grafts with a designed, pre-fabricated vasculature., (Copyright © 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
45. Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2).
- Author
-
Annema W, Nijstad N, Tölle M, de Boer JF, Buijs RV, Heeringa P, van der Giet M, and Tietge UJ
- Subjects
- Acute-Phase Reaction blood, Acute-Phase Reaction chemically induced, Acute-Phase Reaction metabolism, Animals, Atherosclerosis physiopathology, Atherosclerosis prevention & control, Biological Transport, Cells, Cultured, Cholesterol blood, Feces chemistry, Foam Cells metabolism, Group II Phospholipases A2 biosynthesis, Group II Phospholipases A2 blood, Group II Phospholipases A2 genetics, Humans, Lipids blood, Lipoproteins blood, Liver enzymology, Liver metabolism, Mice, Mice, Inbred C57BL, Mice, Transgenic, Middle Aged, Peroxidase administration & dosage, Peroxidase blood, Peroxidase isolation & purification, RNA, Messenger metabolism, Sepsis blood, Serum Amyloid A Protein genetics, Serum Amyloid A Protein metabolism, Steroids metabolism, Acute-Phase Reaction physiopathology, Cholesterol metabolism, Group II Phospholipases A2 physiology, Peroxidase physiology, Serum Amyloid A Protein physiology
- Abstract
Atherosclerosis is linked to inflammation. HDL protects against atherosclerotic cardiovascular disease, mainly by mediating cholesterol efflux and reverse cholesterol transport (RCT). The present study aimed to test the impact of acute inflammation as well as selected acute phase proteins on RCT with a macrophage-to-feces in vivo RCT assay using intraperitoneal administration of [(3)H]cholesterol-labeled macrophage foam cells. In patients with acute sepsis, cholesterol efflux toward plasma and HDL were significantly decreased (P < 0.001). In mice, acute inflammation (75 microg/mouse lipopolysaccharide) decreased [(3)H]cholesterol appearance in plasma (P < 0.05) and tracer excretion into feces both within bile acids (-84%) and neutral sterols (-79%, each P < 0.001). In the absence of systemic inflammation, overexpression of serum amyloid A (SAA, adenovirus) reduced overall RCT (P < 0.05), whereas secretory phospholipase A(2) (sPLA(2), transgenic mice) had no effect. Myeloperoxidase injection reduced tracer appearance in plasma (P < 0.05) as well as RCT (-36%, P < 0.05). Hepatic expression of bile acid synthesis genes (P < 0.01) and transporters mediating biliary sterol excretion (P < 0.01) was decreased by inflammation. In conclusion, our data demonstrate that acute inflammation impairs cholesterol efflux in patients and macrophage-to-feces RCT in vivo in mice. Myeloperoxidase and SAA contribute to a certain extent to reduced RCT during inflammation but not sPLA(2). However, reduced bile acid formation and decreased biliary sterol excretion might represent major contributing factors to decreased RCT in inflammation.
- Published
- 2010
- Full Text
- View/download PDF
46. Role of chemotherapy in gastric MALT lymphoma, diffuse large B-cell lymphoma and other lymphomas.
- Author
-
Raderer M and Paul de Boer J
- Subjects
- Disease-Free Survival, Humans, Lymphoma, B-Cell, Marginal Zone pathology, Lymphoma, Follicular drug therapy, Lymphoma, Follicular pathology, Lymphoma, Large B-Cell, Diffuse pathology, Neoplasm Staging, Stomach Neoplasms pathology, Time Factors, Treatment Outcome, Antineoplastic Agents therapeutic use, Lymphoma, B-Cell, Marginal Zone drug therapy, Lymphoma, Large B-Cell, Diffuse drug therapy, Stomach Neoplasms drug therapy
- Abstract
Primary gastrointestinal lymphomas are relatively common, with the large majority occurring in the stomach. In the commonest histological subtype, i.e. diffuse large B-cell lymphoma (DLCBL), chemotherapy has widely been applied in the past, either following surgery or - in more recent years - as part of conservative management in combination with radiotherapy. Relatively little data, however, exist for chemotherapy as sole treatment modality in localised gastric DLBCL, which nevertheless are highly promising and suggest that combination therapy might overtreat a substantial proportion of patients. In gastric MALT-lymphoma, the use of chemotherapy has been restricted either to patients with a priori disseminated disease or individuals judged to be at high risk or failing local treatment approaches. Only a few prospective phase II studies have been performed, and one controlled trial has shown that chemotherapy was superior in terms of event free survival at ten years when compared to radiation and surgery. These suggest that systemic treatment approaches might be highly effective both in gastric DLBCL as well as MALT-lymphoma, and the scope of this article is to briefly summarize current data on chemotherapy in gastric and GI-lymphomas according to histologic subtypes., (2009. Published by Elsevier Ltd.)
- Published
- 2010
- Full Text
- View/download PDF
47. Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet.
- Author
-
Wiersma H, Nijstad N, de Boer JF, Out R, Hogewerf W, Van Berkel TJ, Kuipers F, and Tietge UJ
- Subjects
- ATP Binding Cassette Transporter, Subfamily G, Member 1, ATP-Binding Cassette Transporters, Animals, Bile metabolism, Cholesterol, Dietary metabolism, Hydrocarbons, Fluorinated pharmacology, Liver X Receptors, Mice, Mice, Inbred C57BL, Mice, Knockout, Orphan Nuclear Receptors agonists, Orphan Nuclear Receptors physiology, Sulfonamides pharmacology, Cholesterol blood, Cholesterol, HDL blood, Lipoproteins deficiency
- Abstract
Objective: The ATP Binding Cassette transporter G1 (ABCG1) has been implicated in cholesterol efflux towards HDL and reverse cholesterol transport (RCT). Biliary cholesterol secretion is considered as an important step in RCT. The aim of the present study was to determine the consequences of Abcg1 deficiency on plasma HDL, liver cholesterol metabolism and biliary cholesterol secretion under conditions of feeding either chow or a 1% cholesterol diet (HCD) or treatment with the LXR agonist T0901317., Methods and Results: Abcg1 expression specifically in hepatocytes is induced by both HCD (p<0.01) and T0901317 (p<0.001). HCD or T0901317 treatment resulted in significantly lower plasma HDL cholesterol levels in Abcg1 knockout mice compared with controls (p<0.05) consistent with a role of Abcg1 in cholesterol efflux towards HDL. Liver lipid composition was not affected by the absence of Abcg1. Biliary cholesterol secretion was 47% higher in Abcg1(-/-) mice on HCD (p<0.05) and not different in the chow and the T0901317 groups. The hepatic gene expression profile indicated uniformly throughout the different treatment groups decreased expression of Srebp2 and its target genes HmgCoA reductase (p<0.05) and LDL receptor (p<0.05) in Abcg1(-/-) mice., Conclusion: These data demonstrate that Abcg1 (i) contributes to plasma HDL cholesterol levels under conditions of dietary and pharmacological Lxr activation and (ii) might mediate, under conditions of hepatic cholesterol loading, hepatocyte cholesterol efflux towards plasma from a pool accessible for biliary secretion resulting in increased biliary cholesterol output when Abcg1 is lacking.
- Published
- 2009
- Full Text
- View/download PDF
48. In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma.
- Author
-
Knoops L, Haas R, de Kemp S, Majoor D, Broeks A, Eldering E, de Boer JP, Verheij M, van Ostrom C, de Vries A, van't Veer L, and de Jong D
- Subjects
- Adult, Aged, Aged, 80 and over, Apoptosis radiation effects, Female, Gamma Rays, Gene Expression Profiling, Humans, Immunoenzyme Techniques, Lymphoma, B-Cell genetics, Lymphoma, B-Cell immunology, Lymphoma, B-Cell radiotherapy, Lymphoma, Large B-Cell, Diffuse genetics, Lymphoma, Large B-Cell, Diffuse immunology, Lymphoma, Large B-Cell, Diffuse radiotherapy, Male, Middle Aged, Mutation, Oligonucleotide Array Sequence Analysis, RNA, Messenger analysis, Gene Expression Regulation, Neoplastic physiology, Lymphoma, Follicular immunology, Lymphoma, Follicular radiotherapy, Tumor Suppressor Protein p53 genetics
- Abstract
Very low-dose irradiation (2 x 2 Gy) is a new, effective, and safe local treatment for follicular lymphoma. To understand the biologic mechanisms of this extremely effective response, we compared by microarray the gene-expression profile of patients' biopsies taken before and after radiation. In all patients, a major and consistent induction of p53 target genes was seen. p53 targets involved in cell-cycle arrest and apoptosis showed the same mode of regulation, indicating that, in vivo, both are activated simultaneously. p53 up-regulation and p53-mediated proliferation arrest and apoptosis were substantiated using immunohistochemistry, with activation of both the intrinsic and the extrinsic apoptotic pathways. The other induced genes revealed a whole set of biologically meaningful genes related to macrophage activation and TH1 immune response. Immunohistochemical analysis suggested a specific activation or differentiation of resident macrophages by apoptotic cells. These biologic insights are important arguments to advocate the use of low-dose radiotherapy as an effective palliative treatment for follicular lymphoma. Moreover, this study is the first in vivo report of the radiation-induced p53 apoptotic response in patients and suggests that this apoptotic response is not immunologically silent.
- Published
- 2007
- Full Text
- View/download PDF
49. Late cardiotoxicity after treatment for Hodgkin lymphoma.
- Author
-
Aleman BM, van den Belt-Dusebout AW, De Bruin ML, van 't Veer MB, Baaijens MH, de Boer JP, Hart AA, Klokman WJ, Kuenen MA, Ouwens GM, Bartelink H, and van Leeuwen FE
- Subjects
- Adult, Cardiovascular Diseases epidemiology, Cohort Studies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Risk Factors, Survival Rate, Time Factors, Antineoplastic Agents adverse effects, Antineoplastic Agents therapeutic use, Cardiovascular Diseases chemically induced, Cardiovascular Diseases pathology, Hodgkin Disease drug therapy, Hodgkin Disease pathology
- Abstract
We assessed cardiovascular disease (CVD) incidence in 1474 survivors of Hodgkin lymphoma (HL) younger than 41 years at treatment (1965-1995). Multivariable Cox regression and competing risk analyses were used to quantify treatment effects on CVD risk. After a median follow-up of 18.7 years, risks of myocardial infarction (MI) and congestive heart failure (CHF) were strongly increased compared with the general population (standardized incidence ratios [SIRs] = 3.6 and 4.9, respectively), resulting in 35.7 excess cases of MI and 25.6 excess cases of CHF per 10 000 patients/year. SIRs of all CVDs combined remained increased for at least 25 years and were more strongly elevated in younger patients. Mediastinal radiotherapy significantly increased the risks of MI, angina pectoris, CHF, and valvular disorders (2- to 7-fold). Anthracyclines significantly added to the elevated risks of CHF and valvular disorders from mediastinal RT (hazard ratios [HRs] were 2.81 and 2.10, respectively). The 25-year cumulative incidence of CHF after mediastinal radiotherapy and anthracyclines in competing risk analyses was 7.9%. In conclusion, risks of several CVDs are 3- to 5-fold increased in survivors of HL compared with the general population, even after prolonged follow-up, leading to increasing absolute excess risks over time. Anthracyclines further increase the elevated risks of CHF and valvular disorders from mediastinal radiotherapy.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.